Flow cytometry (Figure 7B) shows that the introduction of IL-2Rγ chain or JAK3 does not modify cytokeratins and vimentin expressions on untreated and rhIL-15-treated RCC (data not shown). Here, JAK3 is linked to renal cell carcinoma.